Mouse Transmembrane protein 222 (Tmem222) is a 208-amino acid protein encoded by the Tmem222 gene. It contains three predicted transmembrane domains and a domain of unknown function (DUF778) . The protein shares 95% identity and 96% similarity with its human ortholog . Despite this high conservation, there may be subtle functional differences between species, particularly in tissue-specific expression patterns.
When studying Tmem222, researchers should consider these species-specific differences when extrapolating findings between mouse models and human studies. The high degree of conservation suggests evolutionary significance of this protein across mammals, with both mouse and human versions predicted to localize to secretory vesicles .
Tmem222 primarily localizes to early endosomes in synapses of mature neurons, as demonstrated in human iPSC-derived neurons . For visualization, researchers can employ:
Fluorescence microscopy techniques using antibodies against Tmem222
Transfection with fluorescently tagged Tmem222 constructs (C2-GFP-TMEM222)
Co-localization studies with endosomal markers
Methodologically, researchers should:
Use Gateway cloning systems to create expression constructs
Transfect neuronal cell lines using appropriate reagents like FuGene HD
Employ confocal microscopy for high-resolution imaging
Validate localization using subcellular fractionation followed by Western blotting
For optimized visualization, consider using HEK293T cells initially to establish protocols before moving to neuronal systems, as demonstrated in previous studies that verified Tmem222 expression using anti-TMEM222 antibodies (such as NBP2–49295 from Novus Biologicals) .
Tmem222 demonstrates a widespread but variable expression pattern across different tissues. While comprehensive mouse-specific expression data is limited, the human ortholog shows 3.8 times higher expression than the average gene in databases . Based on human data, highest expression levels are found in:
For researchers investigating tissue-specific expression:
Consider quantitative RT-PCR using tissue-specific RNA samples
Follow protocols similar to those used in human studies, which employed SuperScript VILO Master Mix for cDNA synthesis
Analyze using the ΔΔCt method on systems like ABI PRISM 7900HT
Validate findings with protein-level analysis using Western blotting
Multiple expression systems have been successfully used to produce Recombinant Mouse Tmem222, each with specific advantages:
| Expression System | Tag Options | Benefits | Considerations |
|---|---|---|---|
| E. coli | His | High yield, cost-effective | May lack post-translational modifications |
| HEK293 (mammalian cells) | DDK, Myc, His, Avi, Fc | Proper folding and modifications | Lower yield, higher cost |
| Other mammalian cells | His | Physiological modifications | System-specific optimization required |
When selecting an expression system, consider:
Whether post-translational modifications are critical for your research
Required protein yield
Downstream applications (structural studies, functional assays)
Tag compatibility with experimental design
For studies focusing on neuronal function, mammalian expression systems are recommended as they provide proper protein folding and modifications that may be crucial for functionality .
Purification strategies depend on the tags incorporated into your recombinant construct. Based on available recombinant proteins, recommended approaches include:
For His-tagged Tmem222:
Immobilized metal affinity chromatography (IMAC)
Buffer optimization to maintain membrane protein stability
Consider mild detergents to solubilize membrane domains
For DDK/Myc-tagged Tmem222:
Immunoaffinity chromatography
Anti-DDK or anti-Myc antibody columns
For Avi-Fc-His-tagged Tmem222:
Sequential purification using multiple tags
Protein A/G columns for Fc-tag purification followed by IMAC
When purifying transmembrane proteins like Tmem222, special consideration should be given to maintaining protein structure and function by including appropriate detergents in all buffers and optimizing salt concentrations to prevent aggregation .
Common challenges in Tmem222 expression and troubleshooting approaches include:
Low expression levels:
Optimize codon usage for the expression system
Test different promoters for improved expression
Consider inducible expression systems for potentially toxic proteins
Protein insolubility/aggregation:
Modify lysis conditions with different detergents
Test expression at lower temperatures
Consider fusion partners that enhance solubility
Degradation:
Include protease inhibitors in all buffers
Reduce expression time
Analyze for potential proteolytic sites and modify accordingly
Non-functional protein:
Verify protein folding using circular dichroism
Test different tags and tag positions
Consider native purification conditions
When working with Tmem222, researchers should validate expression using Western blotting with antibodies against both the protein and the tag, as demonstrated in previous studies using anti-TMEM222 (1:2,000; catalog number NBP2–49295, Novus Biologicals) and anti-tubulin (1:2,000; catalog number T5326, Sigma Aldrich) for normalization .
Given Tmem222's localization to early endosomes in synapses, several approaches are recommended:
Electrophysiological recordings:
Patch-clamp recordings in Tmem222 knockout/knockdown neurons
Analysis of synaptic transmission parameters
Long-term potentiation/depression studies
High-resolution imaging:
Super-resolution microscopy to track Tmem222 dynamics
Live-cell imaging with fluorescently tagged Tmem222
FRAP (Fluorescence Recovery After Photobleaching) for mobility studies
Proteomic approaches:
Co-immunoprecipitation to identify interacting partners
Proximity labeling methods (BioID, APEX)
Quantitative proteomics comparing wild-type vs. mutant conditions
Functional assays:
Endosomal trafficking assays
Synaptic vesicle recycling analyses
Calcium imaging during neuronal activity
When designing these experiments, researchers should include appropriate controls and consider the developmental timing of Tmem222 expression, as its role may vary during different stages of neuronal maturation .
While most research has focused on human TMEM222 mutations, these findings provide valuable insights for mouse studies:
Biallelic variants in human TMEM222 have been identified in 17 individuals from nine unrelated families, presenting with:
Intellectual disability (primary phenotype)
Aggressive behavior
Shy character
Body tremors
Decreased muscle mass in lower extremities
For researchers studying mouse models:
Consider generating equivalent mutations in mouse Tmem222 using CRISPR/Cas9
Develop comprehensive behavioral testing protocols including:
Cognitive assessments (Morris water maze, novel object recognition)
Motor function evaluations (rotarod, grip strength)
Social interaction paradigms
Analyze neuronal morphology and synapse formation in mutant models
Evaluate endosomal trafficking in neurons derived from mutant mice
The high expression of Tmem222 in human brain, particularly in the parietal and occipital cortex, suggests focusing on these regions when studying neurodevelopmental impacts in mouse models .
Given Tmem222's localization and potential role in neurodevelopment, several approaches are recommended for studying its interactions:
Co-immunoprecipitation (Co-IP):
Use anti-Tmem222 antibodies or antibodies against the tag in recombinant versions
Crosslinking may be necessary to capture transient interactions
Consider native vs. denaturing conditions depending on interaction stability
Proximity-based methods:
BioID fusion with Tmem222 to identify proximal proteins in living cells
APEX2 fusion for temporal control of proximity labeling
Split-GFP complementation for direct visualization of interactions
Yeast two-hybrid screening:
Consider membrane yeast two-hybrid systems for transmembrane proteins
Use soluble domains of Tmem222 as bait for conventional Y2H
Interactome analysis:
Mass spectrometry after Co-IP or proximity labeling
Compare interactomes in different neuronal states or developmental stages
Validate key interactions with multiple methods
When performing these studies, researchers should be aware that the transmembrane nature of Tmem222 may complicate certain interaction studies, necessitating optimization of detergent conditions to solubilize the protein while maintaining interaction potential .
Tmem222 shows remarkable conservation across evolutionary diverse species, suggesting fundamental biological importance:
| Species | Common Name | Protein Length | Similarity to Human | Identity to Human |
|---|---|---|---|---|
| Rattus norvegicus | Rat | 208aa | 99% | 96% |
| Canis familiaris | Dog | 208aa | 98% | 96% |
| Mus musculus | Mouse | 208aa | 96% | 95% |
| Sus scrofa | Pig | 208aa | 97% | 94% |
| Equus caballus | Horse | 207aa | 94% | 93% |
| Gallus gallus | Chicken | 182aa | 90% | 85% |
| Danio rerio | Zebrafish | 174aa | 83% | 71% |
| Drosophila melanogaster | Fruit Fly | 196aa | 74% | 61% |
| Anopheles gambiae | Mosquito | 197aa | 66% | 53% |
This high conservation suggests:
Tmem222 likely serves a fundamental cellular function conserved through evolution
The protein's structure-function relationship is tightly constrained
Findings from mouse models may translate well to human applications
Invertebrate models could potentially be used for basic functional studies
Research approaches to leverage this conservation include:
Complementation studies across species
Domain swapping between orthologs to identify functional regions
Comparative analysis of expression patterns and interactomes across species
Despite the high sequence similarity (95% identity) between mouse and human TMEM222, potential functional differences may exist:
Expression patterns:
While both show high brain expression, tissue-specific differences may exist
Developmental timing of expression may vary between species
Protein interactions:
Species-specific interaction partners may drive functional differences
Conserved interactions likely represent core functions
Post-translational modifications:
Different modification patterns may affect localization or function
Modified residues may vary between species despite sequence conservation
To investigate these differences:
Perform comparative expression profiling across tissues and developmental stages
Conduct parallel interaction studies in both species
Analyze post-translational modifications using mass spectrometry
Test functional complementation by expressing mouse Tmem222 in human cells with TMEM222 knockdown and vice versa
Understanding these nuances is critical when extrapolating findings from mouse models to human disease contexts, particularly for neurodevelopmental disorders linked to TMEM222 mutations .
Generating Tmem222 knockout mice:
CRISPR/Cas9 approach:
Design guide RNAs targeting early exons of Tmem222
Screen for frameshift mutations that result in complete loss of protein
Validate knockout at mRNA and protein levels
Conditional knockout strategy:
Generate floxed Tmem222 alleles
Cross with tissue-specific or inducible Cre lines
Particularly valuable for studying neuronal functions while avoiding potential developmental lethality
Knockin reporter approach:
Replace Tmem222 coding sequence with a reporter (GFP/LacZ)
Enables tracking of cell populations normally expressing Tmem222
Based on human disease associations, expected phenotypes may include:
Neurodevelopmental abnormalities
Cognitive deficits
Behavioral changes (potentially including aggression)
Motor coordination issues
Muscle mass abnormalities, particularly in lower limbs
When analyzing these models, comprehensive phenotyping should include:
Behavioral testing batteries
Electrophysiological assessment of neuronal function
Histological analysis of brain development
Molecular characterization of endosomal trafficking
When investigating Tmem222 localization in neurons, several controls are essential:
Antibody specificity controls:
Peptide competition assays
Parallel staining in Tmem222 knockout/knockdown cells
Multiple antibodies targeting different epitopes
Organelle markers for co-localization:
Early endosome markers (Rab5, EEA1)
Late endosome markers (Rab7)
Recycling endosome markers (Rab11)
Synaptic vesicle markers (Synaptophysin)
Post-synaptic markers (PSD-95)
Expression level controls:
Compare endogenous vs. overexpressed protein localization
Use inducible expression systems to control expression levels
Consider knockin approaches for physiological expression levels
Methodological controls:
Live vs. fixed cell imaging comparisons
Multiple fixation methods to rule out fixation artifacts
Super-resolution vs. conventional microscopy validation
Previous research has demonstrated Tmem222 localization to early endosomes in synapses of mature iPSC-derived neurons, suggesting a role in endosomal trafficking within the synapse. This finding should be validated in mouse neurons using similar methodological approaches .
Based on current knowledge, several promising research avenues include:
Endosomal trafficking role:
Investigate how Tmem222 influences receptor internalization and recycling
Examine effects on synapse formation and maintenance
Study potential roles in neuronal polarization and axon/dendrite development
Synaptic plasticity:
Analyze Tmem222's role in long-term potentiation and depression
Investigate activity-dependent regulation of Tmem222 expression or localization
Study effects of Tmem222 mutations on learning and memory
Interactome mapping:
Comprehensive identification of Tmem222 binding partners
Temporal analysis of interactions during development
Comparison of wild-type vs. disease-associated variant interactomes
Signaling pathway integration:
Investigate whether Tmem222 functions within known neurodevelopmental signaling pathways
Examine phosphorylation states and regulatory mechanisms
Study potential roles in growth factor receptor trafficking
Therapeutic targeting:
Screen for small molecules that modulate Tmem222 function
Explore gene therapy approaches for disease-associated variants
Develop biomarkers for Tmem222-associated pathologies
These research directions should be pursued using a combination of in vitro neuronal cultures, mouse models, and potentially organoid systems to comprehensively understand Tmem222's neuronal functions .
Researchers new to Tmem222 should consider:
Expression system selection:
Choose based on experimental needs and downstream applications
Consider HEK293 mammalian expression for neuronal studies
E. coli systems may be sufficient for structural analyses
Construct design:
Tag placement can significantly impact function
Consider the transmembrane topology when designing constructs
Include appropriate controls (empty vector, inactive mutants)
Validation strategies:
Confirm expression using Western blotting
Verify localization with immunofluorescence
Assess function with appropriate assays
Experimental controls:
Generate knockout/knockdown systems
Include wild-type controls in all experiments
Consider rescue experiments to confirm specificity
Translational relevance:
Connect findings to human disease contexts
Consider cross-species validation of key findings
Develop models that recapitulate human pathology